Women in skin cancer vol II: 2022 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Women in skin cancer vol II: 2022 PDF full book. Access full book title Women in skin cancer vol II: 2022 by Sapna Patel. Download full books in PDF and EPUB format.
Author: Sapna Patel
Publisher: Frontiers Media SA
ISBN: 283253306X
Category : Medical
Languages : en
Pages : 84
Get Book
Book Description
Author: Sapna Patel
Publisher: Frontiers Media SA
ISBN: 283253306X
Category : Medical
Languages : en
Pages : 84
Get Book
Book Description
Author: Cinzia Lanzi
Publisher: Frontiers Media SA
ISBN: 2832530591
Category : Medical
Languages : en
Pages : 309
Get Book
Book Description
Author: Nadia M. Hamdy
Publisher: Frontiers Media SA
ISBN: 2832525636
Category : Medical
Languages : en
Pages : 134
Get Book
Book Description
Author: Margaret Gatti-Mays
Publisher: Frontiers Media SA
ISBN: 2832538347
Category : Medical
Languages : en
Pages : 217
Get Book
Book Description
We are delighted to present the Frontiers in Oncology "Women in Breast Cancer” Volume II series of article collections. At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Author: Samata Kakkad
Publisher: Frontiers Media SA
ISBN: 2832518443
Category : Medical
Languages : en
Pages : 172
Get Book
Book Description
Author: Sharon Prince
Publisher: Frontiers Media SA
ISBN: 2832525431
Category : Medical
Languages : en
Pages : 206
Get Book
Book Description
Author: U.s. Department of Health and Human Services
Publisher: Createspace Independent Publishing Platform
ISBN: 9781502903853
Category : Medical
Languages : en
Pages : 112
Get Book
Book Description
Skin cancer is the most commonly diagnosed cancer in the United States, yet most cases are preventable. Every year in the United States, nearly 5 million people are treated for skin cancer, at an estimated cost of $8.1 billion. Melanoma, the most deadly form of skin cancer, causes nearly 9,000 deaths each year. Despite recent efforts to address risk factors, skin cancer rates continue to rise. While those with lighter skin are more susceptible, anyone can get skin cancer—and it can be serious, even deadly. Almost all of the conditions can be caused by unnecessary ultraviolet (UV) radiation exposure, usually from excessive time in the sun or from the use of indoor tanning devices. It is alarming that every year, nearly one out of every three young white women aged 16–25 engages in indoor tanning. It's important to shatter the myth that tanned skin is a sign of health. And a “base” tan is not a “safe” tan. Tanned skin is damaged skin. Understanding the risk of UV exposure is crucial to protecting ourselves and our loved ones. That is why “The Surgeon General's Call to Action to Prevent Skin Cancer” is important for all of us. It outlines action steps we can all take—as individuals, parents, educators, employers, policy makers, health care professionals, and communities—to reverse this alarming trend. As a nation, we can all do more to address skin cancer as a serious public health challenge. Everyone is urged to find out more about the risk of skin cancer—and what we all can do to prevent it.
Author: Yong-mi Kim
Publisher: Frontiers Media SA
ISBN: 2832529682
Category : Medical
Languages : en
Pages : 164
Get Book
Book Description
Author: Linda Keilman
Publisher: Elsevier Health Sciences
ISBN: 0323986781
Category : Medical
Languages : en
Pages : 182
Get Book
Book Description
Advances in Family Practice Nursing reviews the year’s most important findings and updates within the field in order to provide family nurse practitioners with the current clinical information they need provide optimal primary care to patients. A distinguished editorial board, led by Dr. Linda Keilman, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in family practice nursing inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care. Contains 20 articles on such topics as food insecurity in older adults; COVID and older adults; care for women with past trauma; the source of fever in children; mental health issues in children and adolescents during the COVID-19 pandemic; when it’s not just ADHD: coexisting depression and anxiety in pediatric primary care; new medications for ADHD; and more. Provides in-depth, clinical reviews in family practice nursing, providing actionable insights for clinical practice. Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author: Robert Bazell
Publisher: Random House
ISBN: 0307764982
Category : Health & Fitness
Languages : en
Pages : 241
Get Book
Book Description
Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
